Zürich, Switzerland Archives

Search for:

What we do
Inizio

Inizio is a strategic partner for health and life sciences with a full suite of advisory, medical, marketing, communications and patient and stakeholder engagement services.

Biotech
Personalized solutions curated to maximize asset value at every opportunity.

EmerGENE
Guiding transformational cell and gene therapies on the pathway to their patients.
Our Business Units

Our five specialist business units support health and life science companies from early discovery to making a difference in the lives of patients.

Advisory

Medical

MarComms

Engage

Biotech
Who we are
- Leadership team
- Locations
What matters to us
Insights
View all insights
Imagine a future at Inizio Medical: Matt Booth, SVP Global Therapy Lead

Matt Booth, SVP, Global Therapy Lead at MEDiSTRAVA, discusses what being part of Inizio Medical means to him and his vision for the future.
Read more

Imagine a future at Inizio Medical: Aya-Takemoto Tokaji, SVP, Medical Affairs

Across all teams at Inizio Medical, we are united in our goal to redefine the role of Medical in drug development and...
Read more

Inizio strengthens senior team with DE&I appointment

Inizio has strengthened its senior leadership team with the appointment of Stefanie Christmas as its new Global Head of Diversity, Equity & Inclusion
Read more

Inizio sets out ambitions to achieve net zero by 2040

Working towards this goal, Inizio will shortly submit scope 1, 2 & 3 near-term carbon reduction targets to the Science Based Targets initiative (SBTi)
Read more

It’s time to do the right thing: How our pro bono work is making a difference

At Inizio, our pro bono activities support causes that align with our values to positively impact the communities we serve and society as a whole.
Read more

Implementing omnichannel to improve HCP engagement

Vynamic helps a life sciences client implement and embrace omnichannel to drive customer engagement and accelerate brand performance.
Read more

7 Biotech Insights to Maximize Your Asset’s Value

Read our latest infographic for seven key insights that will help you maximize asset value at every possible opportunity
Read more

The Phase II Inflection Point: Investing to Maximize Asset Value

In this eBook, we share the combined expertise of subject matter experts across Inizio to help you effectively navigate Phase II of your biotech
Read more
Join Inizio
- Being Part of Inizio
- Vacancies

Contact

Search for:
- - Biotech
  - EmerGENE
- - Advisory
  - Medical
  - MarComms
  - Engage
  - Biotech
- Leadership team
- Locations
- Being Part of Inizio
- Vacancies
Insights
Contact

enquiries@inizio.health

Who we are

What we do
- Inizio
- EmerGENE
- Biotech

Business Units
- Advisory
- Medical
- MarComms
- Engage
- Biotech

Join Inizio

Privacy Policy

/

Modern Slavery & Human Trafficking Statement

/

Shareholder Queries

/

Privacy Shield Policy

/

Sustainability Report

/

UK Tax Strategy Statement

/

Applying for a role with us

/

Cookies Settings

Inizio

Our Business Units

Imagine a future at Inizio Medical: Matt Booth, SVP Global Therapy Lead

Imagine a future at Inizio Medical: Aya-Takemoto Tokaji, SVP, Medical Affairs

Inizio strengthens senior team with DE&I appointment

Inizio sets out ambitions to achieve net zero by 2040

It’s time to do the right thing: How our pro bono work is making a difference

Implementing omnichannel to improve HCP engagement

7 Biotech Insights to Maximize Your Asset’s Value

The Phase II Inflection Point: Investing to Maximize Asset Value